Alcobra (ADHD)

Add to Watchlists
Create an Alert
4.18 +0.02  +0.48% NASDAQ Apr 28, 17:54 Delayed 2m USD
View Full Chart
ADHD Price Chart
View All Performance Charts

ADHD Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • URL: http://www.alcobra-pharma.com
  • Investor Relations URL: http://www.alcobra-pharma.com/indexInvestor.cfm
  • HQ Country: Israel
  • HQ State/Province: N/A
  • Incorporation Country: Israel
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: N/A
  • NAICS Name: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Alcobra Ltd is a biopharmaceutical company. It is engaged in the development & commercialization of drug candidate, to treat Attention Deficit Hyperactivity Disorder, (ADHD), and other cognitive dysfunctions including Fragile X.

ADHD Comparables

Edit

ADHD Excel Add-In Codes

  • Name: =YCI("ADHD","name")
  • Description: =YCI("ADHD","description")
  • Sector: =YCI("ADHD","sector")
  • Industry: =YCI("ADHD","industry")
  • Est. Current Fiscal Year End: =YCI("ADHD","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.